Sharone Green1, Alan Rothman. 1. University of Massachusetts Medical School, Center for Infectious Disease and Vaccine Research, Worcester, Massachusetts 01655, USA.
Abstract
PURPOSE OF REVIEW: The continued emergence of dengue virus infection and its severe disease manifestation, dengue hemorrhagic fever, is a growing public health problem. The majority of severe infections occur upon secondary encounters with heterologous dengue virus serotypes, suggesting an immune-mediated process. RECENT FINDINGS: Significant findings in the past year include a greater understanding of dengue virus interactions with target cells such as dendritic cells, hepatocytes and endothelial cells. Infection of these cells results in the production of immune mediators that then shape the adaptive humoral and cellular immune response. The circulation of high levels of secreted NS1 in the presence of pre-existing heterologous non-neutralizing antibody may mediate complement activation and trigger plasma leakage. The role of enhancing antibodies in disease pathogenesis remains unclear. Recent studies demonstrate low avidity crossreactive T cells, which may produce an altered profile of cytokines leading to plasma leakage. Ongoing prospective studies that include epidemiological, virological and immunological risk factors are crucial to our understanding of the mechanisms of immunopathogenesis of dengue hemorrhagic fever. SUMMARY: The immune mechanisms that lead to dengue hemorrhagic fever are complex and need to be elucidated further for the development of therapeutics as well as safe and efficacious dengue vaccines.
PURPOSE OF REVIEW: The continued emergence of dengue virus infection and its severe disease manifestation, dengue hemorrhagic fever, is a growing public health problem. The majority of severe infections occur upon secondary encounters with heterologous dengue virus serotypes, suggesting an immune-mediated process. RECENT FINDINGS: Significant findings in the past year include a greater understanding of dengue virus interactions with target cells such as dendritic cells, hepatocytes and endothelial cells. Infection of these cells results in the production of immune mediators that then shape the adaptive humoral and cellular immune response. The circulation of high levels of secreted NS1 in the presence of pre-existing heterologous non-neutralizing antibody may mediate complement activation and trigger plasma leakage. The role of enhancing antibodies in disease pathogenesis remains unclear. Recent studies demonstrate low avidity crossreactive T cells, which may produce an altered profile of cytokines leading to plasma leakage. Ongoing prospective studies that include epidemiological, virological and immunological risk factors are crucial to our understanding of the mechanisms of immunopathogenesis of dengue hemorrhagic fever. SUMMARY: The immune mechanisms that lead to dengue hemorrhagic fever are complex and need to be elucidated further for the development of therapeutics as well as safe and efficacious dengue vaccines.
Authors: Irina Gutsche; Fasséli Coulibaly; James E Voss; Jérôme Salmon; Jacques d'Alayer; Myriam Ermonval; Eric Larquet; Pierre Charneau; Thomas Krey; Françoise Mégret; Eric Guittet; Félix A Rey; Marie Flamand Journal: Proc Natl Acad Sci U S A Date: 2011-04-25 Impact factor: 11.205
Authors: Allan R Brasier; Hyunsu Ju; Josefina Garcia; Heidi M Spratt; Sundar S Victor; Brett M Forshey; Eric S Halsey; Guillermo Comach; Gloria Sierra; Patrick J Blair; Claudio Rocha; Amy C Morrison; Thomas W Scott; Isabel Bazan; Tadeusz J Kochel Journal: Am J Trop Med Hyg Date: 2012-02 Impact factor: 2.345
Authors: Isaac Farias Cansanção; Ana Paula Santos do Carmo; Robério Dias Leite; Rosana Deyse Ponte Portela; Sérgio de Sá Leitão Paiva Júnior; Valdir de Queiroz Balbino; Silvia Helena Barem Rabenhorst Journal: Inflamm Res Date: 2016-07-19 Impact factor: 4.575